TOI
The Oncology Institute, Inc.$3.42+0.09 (+2.55%)Prev Close$3.33·MCap$329.1M·P/E—·Vol447.8K·Yield—
▲
Buys (12M)
6
$2.00M
▼
Sells (12M)
9
$34.76M
◆
Net Activity
Net Seller
$32.76M
●
Active Insiders
6
last 12 mo
Over the past 12 months, insider activity at The Oncology Institute, Inc. (TOI) has been dominated by selling, with 6 insider purchases totaling $2.00M and 9 insider sales totaling $34.76M. The most recent insider transaction was by Kaushal Mohit (director), who sold $335.1K worth of shares on Apr 16, 2026. The Oncology Institute, Inc. operates in the Healthcare sector, within the Medical - Care Facilities industry, with a market cap of $329.1M.
TOI Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Apr 16, 2026 | Kaushal Mohit | director | Sell | 95,719 | $3.50 | $335.1K | 211,016-31% |
| Apr 13, 2026 | Chernett Jorey | 10 percent owner | Buy | 20,000 | $3.10 | $62.0K | 10,499,358 |
| Mar 30, 2026 | Chernett Jorey | 10 percent owner | Buy | 27,429 | $2.96 | $81.2K | 10,479,358 |
| Mar 27, 2026 | Chernett Jorey | 10 percent owner | Buy | 50,000 | $3.15 | $157.5K | 10,451,929 |
| Mar 25, 2026 | Chernett Jorey | 10 percent owner | Buy | 125,000 | $3.11 | $388.8K | 10,401,929 |
| Mar 23, 2026 | Chernett Jorey | 10 percent owner | Buy | 25,000 | $3.35 | $83.8K | 10,276,929 |
| Mar 17, 2026 | Chernett Jorey | 10 percent owner | Buy | 398,985 | $3.07 | $1.23M | 10,251,929 |
| Jan 5, 2026 | Carter Robert Ross | officer: Chief Financial Officer | Sell | 247 | $3.56 | $879.32 | 235,122 |
| Dec 16, 2025 | Hively Brad | Director | Sell | 13,333 | $3.77 | $50.3K | 683,721 |
| Nov 20, 2025 | Pacala Mark L | Director | Sell | 50,000 | $4.00 | $200.0K | 222,811 |
| Sep 5, 2025 | M33 Growth I L.P. | Director | Sell | 6,700,000 | $3.09 | $20.70M6.8% OS | 7,932,389-46% |
| Aug 21, 2025 | Hively Brad | Director | Sell | 20,221 | $4.06 | $82.1K | 622,980 |
| Jun 9, 2025 | M33 Growth I L.P. | Director | Sell | 750,000 | $3.05 | $2.29M0.8% OS | 13,950,557 |
| Jun 5, 2025 | Hively Brad | Director | Sell | 1,976,137 | $2.87 | $5.67M2.0% OS | 712,033-74% |
| May 22, 2025 | M33 Growth I L.P. | Director | Sell | 2,000,000 | $2.71 | $5.43M2.0% OS | 14,624,233 |
| Mar 28, 2025 | Hively Brad | Director | Buy | 9,056 | $1.04 | $9.4K | 675,809 |
| Mar 28, 2025 | Johnson Karen Marie | Director | Buy | 36,224 | $1.04 | $37.7K | 203,409 |
| Mar 28, 2025 | Podnos Yale | Chief Medical Officer | Buy | 9,056 | $1.04 | $9.4K | 79,049 |
| Mar 28, 2025 | Pacala Mark L | Director | Buy | 90,562 | $1.04 | $94.3K | 224,971+67% |
| Mar 28, 2025 | Castle Jeremy | Chief Operating Officer | Buy | 9,056 | $1.04 | $9.4K | 90,386 |
| Mar 28, 2025 | Virnich Daniel | Chief Executive Officer | Buy | 22,640 | $1.04 | $23.6K | 724,363 |
| Mar 28, 2025 | Carter Robert Ross | Chief Financial Officer | Buy | 9,056 | $1.04 | $9.4K | 39,407+30% |
| Mar 28, 2025 | BARASCH RICHARD A | Director | Buy | 1,358,448 | $1.04 | $1.42M1.4% OS | 1,775,641+326% |
| Dec 2, 2024 | Hively Brad | Director | Buy | 300,000 | $0.17 | $50.0K | 666,753+82% |
| Jan 30, 2024 | Havencrest Healthcare Partners, L.P. | Sell | 8,637 | $2.12 | $18.3K | 0Exit | |
| Jan 26, 2024 | Havencrest Healthcare Partners, L.P. | 10% Owner | Sell | 43,776 | $2.21 | $96.8K | 27,498-61% |
| Jan 23, 2024 | Havencrest Healthcare Partners, L.P. | 10% Owner | Sell | 27,587 | $2.12 | $58.6K | 68,014-29% |
| Dec 18, 2023 | Shah Mihir | Chief Financial Officer | Buy | 100,000 | $1.27 | $127.0K | 328,122+44% |
| Nov 21, 2023 | Hively Brad | Director | Sell | 25,000 | $2.24 | $56.0K | 697,065 |
| Nov 15, 2023 | Hively Brad | Director | Sell | 47,000 | $2.52 | $118.6K | 724,182 |
| Mar 21, 2023 | BARASCH RICHARD A | Director | Buy | 30,000 | $0.55 | $16.5K | 237,193 |
| Dec 20, 2022 | Miller Matthew P | Chief Operating Officer | Buy | 73,684 | $0.95 | $70.0K | 175,325+72% |
| Nov 15, 2022 | Havencrest Healthcare Partners, L.P. | 10% Owner | Sell | 365,321 | $2.33 | $851.2K | 13,362,873 |
| Nov 15, 2022 | Kaushal Mohit | Director | Sell | 15,994 | $2.13 | $34.1K | 25,534-39% |
| Nov 10, 2022 | Havencrest Healthcare Partners, L.P. | 10% Owner | Sell | 168,281 | $3.07 | $517.3K | 13,869,475 |
| Nov 7, 2022 | Havencrest Healthcare Partners, L.P. | 10% Owner | Sell | 114,867 | $3.45 | $395.9K | 13,965,842 |
| Nov 2, 2022 | Havencrest Healthcare Partners, L.P. | 10% Owner | Sell | 150,627 | $4.26 | $640.9K | 14,120,114 |
| Oct 28, 2022 | Havencrest Healthcare Partners, L.P. | 10% Owner | Sell | 139,591 | $5.02 | $701.2K | 14,249,060 |
| Oct 25, 2022 | Havencrest Healthcare Partners, L.P. | 10% Owner | Sell | 79,800 | $5.02 | $400.7K | 14,361,360 |
| Oct 25, 2022 | Kaushal Mohit | Director | Sell | 4,798 | $4.96 | $23.8K | 41,528 |
| Oct 20, 2022 | Havencrest Healthcare Partners, L.P. | 10% Owner | Sell | 41,700 | $4.71 | $196.3K | 14,410,860 |
| Oct 17, 2022 | Havencrest Healthcare Partners, L.P. | 10% Owner | Sell | 43,249 | $4.63 | $200.1K | 14,441,109 |
| Oct 12, 2022 | Havencrest Healthcare Partners, L.P. | 10% Owner | Sell | 60,843 | $4.55 | $277.0K | 14,505,652 |
| Oct 7, 2022 | Havencrest Healthcare Partners, L.P. | 10% Owner | Sell | 62,221 | $4.57 | $284.2K | 14,575,313 |
| Oct 4, 2022 | Havencrest Healthcare Partners, L.P. | 10% Owner | Sell | 51,212 | $4.77 | $244.3K | 14,629,585 |
| Sep 29, 2022 | Havencrest Healthcare Partners, L.P. | 10% Owner | Sell | 47,716 | $4.67 | $222.7K | 14,674,227 |
| Sep 26, 2022 | Havencrest Healthcare Partners, L.P. | 10% Owner | Sell | 25,614 | $4.33 | $110.8K | 14,700,829 |
TOI Insider Buying Activity
The following table shows recent insider purchases of The Oncology Institute, Inc. (TOI) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Apr 13, 2026 | Chernett Jorey | 10 percent owner | Buy | 20,000 | $3.10 | $62.0K | 10,499,358 |
| Mar 30, 2026 | Chernett Jorey | 10 percent owner | Buy | 27,429 | $2.96 | $81.2K | 10,479,358 |
| Mar 27, 2026 | Chernett Jorey | 10 percent owner | Buy | 50,000 | $3.15 | $157.5K | 10,451,929 |
| Mar 25, 2026 | Chernett Jorey | 10 percent owner | Buy | 125,000 | $3.11 | $388.8K | 10,401,929 |
| Mar 23, 2026 | Chernett Jorey | 10 percent owner | Buy | 25,000 | $3.35 | $83.8K | 10,276,929 |
| Mar 17, 2026 | Chernett Jorey | 10 percent owner | Buy | 398,985 | $3.07 | $1.23M | 10,251,929 |
| Mar 28, 2025 | Hively Brad | Director | Buy | 9,056 | $1.04 | $9.4K | 675,809 |
| Mar 28, 2025 | Johnson Karen Marie | Director | Buy | 36,224 | $1.04 | $37.7K | 203,409 |
| Mar 28, 2025 | Podnos Yale | Chief Medical Officer | Buy | 9,056 | $1.04 | $9.4K | 79,049 |
| Mar 28, 2025 | Pacala Mark L | Director | Buy | 90,562 | $1.04 | $94.3K | 224,971+67% |
| Mar 28, 2025 | Castle Jeremy | Chief Operating Officer | Buy | 9,056 | $1.04 | $9.4K | 90,386 |
| Mar 28, 2025 | Virnich Daniel | Chief Executive Officer | Buy | 22,640 | $1.04 | $23.6K | 724,363 |
| Mar 28, 2025 | Carter Robert Ross | Chief Financial Officer | Buy | 9,056 | $1.04 | $9.4K | 39,407+30% |
| Mar 28, 2025 | BARASCH RICHARD A | Director | Buy | 1,358,448 | $1.04 | $1.42M1.4% OS | 1,775,641+326% |
| Dec 2, 2024 | Hively Brad | Director | Buy | 300,000 | $0.17 | $50.0K | 666,753+82% |
| Dec 18, 2023 | Shah Mihir | Chief Financial Officer | Buy | 100,000 | $1.27 | $127.0K | 328,122+44% |
| Mar 21, 2023 | BARASCH RICHARD A | Director | Buy | 30,000 | $0.55 | $16.5K | 237,193 |
| Dec 20, 2022 | Miller Matthew P | Chief Operating Officer | Buy | 73,684 | $0.95 | $70.0K | 175,325+72% |
TOI Insider Selling Activity
The following table shows recent insider sales of The Oncology Institute, Inc. (TOI) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Apr 16, 2026 | Kaushal Mohit | director | Sell | 95,719 | $3.50 | $335.1K | 211,016-31% |
| Jan 5, 2026 | Carter Robert Ross | officer: Chief Financial Officer | Sell | 247 | $3.56 | $879.32 | 235,122 |
| Dec 16, 2025 | Hively Brad | Director | Sell | 13,333 | $3.77 | $50.3K | 683,721 |
| Nov 20, 2025 | Pacala Mark L | Director | Sell | 50,000 | $4.00 | $200.0K | 222,811 |
| Sep 5, 2025 | M33 Growth I L.P. | Director | Sell | 6,700,000 | $3.09 | $20.70M6.8% OS | 7,932,389-46% |
| Aug 21, 2025 | Hively Brad | Director | Sell | 20,221 | $4.06 | $82.1K | 622,980 |
| Jun 9, 2025 | M33 Growth I L.P. | Director | Sell | 750,000 | $3.05 | $2.29M0.8% OS | 13,950,557 |
| Jun 5, 2025 | Hively Brad | Director | Sell | 1,976,137 | $2.87 | $5.67M2.0% OS | 712,033-74% |
| May 22, 2025 | M33 Growth I L.P. | Director | Sell | 2,000,000 | $2.71 | $5.43M2.0% OS | 14,624,233 |
| Jan 30, 2024 | Havencrest Healthcare Partners, L.P. | Sell | 8,637 | $2.12 | $18.3K | 0Exit | |
| Jan 26, 2024 | Havencrest Healthcare Partners, L.P. | 10% Owner | Sell | 43,776 | $2.21 | $96.8K | 27,498-61% |
| Jan 23, 2024 | Havencrest Healthcare Partners, L.P. | 10% Owner | Sell | 27,587 | $2.12 | $58.6K | 68,014-29% |
| Nov 21, 2023 | Hively Brad | Director | Sell | 25,000 | $2.24 | $56.0K | 697,065 |
| Nov 15, 2023 | Hively Brad | Director | Sell | 47,000 | $2.52 | $118.6K | 724,182 |
| Nov 15, 2022 | Havencrest Healthcare Partners, L.P. | 10% Owner | Sell | 365,321 | $2.33 | $851.2K | 13,362,873 |
| Nov 15, 2022 | Kaushal Mohit | Director | Sell | 15,994 | $2.13 | $34.1K | 25,534-39% |
| Nov 10, 2022 | Havencrest Healthcare Partners, L.P. | 10% Owner | Sell | 168,281 | $3.07 | $517.3K | 13,869,475 |
| Nov 7, 2022 | Havencrest Healthcare Partners, L.P. | 10% Owner | Sell | 114,867 | $3.45 | $395.9K | 13,965,842 |
| Nov 2, 2022 | Havencrest Healthcare Partners, L.P. | 10% Owner | Sell | 150,627 | $4.26 | $640.9K | 14,120,114 |
| Oct 28, 2022 | Havencrest Healthcare Partners, L.P. | 10% Owner | Sell | 139,591 | $5.02 | $701.2K | 14,249,060 |
| Oct 25, 2022 | Havencrest Healthcare Partners, L.P. | 10% Owner | Sell | 79,800 | $5.02 | $400.7K | 14,361,360 |
| Oct 25, 2022 | Kaushal Mohit | Director | Sell | 4,798 | $4.96 | $23.8K | 41,528 |
| Oct 20, 2022 | Havencrest Healthcare Partners, L.P. | 10% Owner | Sell | 41,700 | $4.71 | $196.3K | 14,410,860 |
| Oct 17, 2022 | Havencrest Healthcare Partners, L.P. | 10% Owner | Sell | 43,249 | $4.63 | $200.1K | 14,441,109 |
| Oct 12, 2022 | Havencrest Healthcare Partners, L.P. | 10% Owner | Sell | 60,843 | $4.55 | $277.0K | 14,505,652 |
| Oct 7, 2022 | Havencrest Healthcare Partners, L.P. | 10% Owner | Sell | 62,221 | $4.57 | $284.2K | 14,575,313 |
| Oct 4, 2022 | Havencrest Healthcare Partners, L.P. | 10% Owner | Sell | 51,212 | $4.77 | $244.3K | 14,629,585 |
| Sep 29, 2022 | Havencrest Healthcare Partners, L.P. | 10% Owner | Sell | 47,716 | $4.67 | $222.7K | 14,674,227 |
| Sep 26, 2022 | Havencrest Healthcare Partners, L.P. | 10% Owner | Sell | 25,614 | $4.33 | $110.8K | 14,700,829 |
TOI Insiders
Similar Stocks to TOI
HCA
HCA Healthcare, Inc.
$432.22-3.08%
$106.92B
THC
Tenet Healthcare Corporation
$178.81-3.77%
$16.25B
SOLV
Solventum Corporation
$67.83-2.79%
$11.97B
UHS
Universal Health Services, Inc.
$166.56-7.21%
$11.35B
ENSG
The Ensign Group, Inc.
$187.86-1.10%
$11.14B
EHC
Encompass Health Corporation
$101.23+0.31%
$10.34B
DVA
DaVita Inc.
$150.76+0.47%
$10.02B
CHE
Chemed Corporation
$425.56+0.59%
$5.14B